Trial Profile
A Phase 2 Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Barasertib (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 01 Jul 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 03 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Oct 2011 Actual initiation date (Sep 2011) added as reported by ClinicalTrials.gov.